Sterling Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36K Buy
1,768
+1,509
+583% +$30.7K ﹤0.01% 1593
2025
Q1
$4.7K Sell
259
-175
-40% -$3.18K ﹤0.01% 2193
2024
Q4
$11K Buy
434
+336
+343% +$8.49K ﹤0.01% 2119
2024
Q3
$3.33K Buy
+98
New +$3.33K ﹤0.01% 1939